| Ashley Welch, APRN, NP-C | |
|
4935 Southfork Dr, Lakeland, FL 33813-2000 | |
| (863) 646-3376 | |
| Not Available |
| Full Name | Ashley Welch |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 4935 Southfork Dr, Lakeland, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073270070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | APRN11013202 (Florida) | Primary |
| Entity Name | Florida Joint & Spine Institute Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992705487 PECOS PAC ID: 0547168114 Enrollment ID: O20031222000840 |
News Archive
Overweight Latino children who consume lots of sugar-especially in sugary drinks-show signs of beta cell decline, a precursor of type 2 diabetes, according to researchers at the Keck School of Medicine of the University of Southern California.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
Study findings support the use of the Overall Anxiety Severity And Impairment Scale as a brief measure of anxiety in the outpatient clinical setting.
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
Amgen, the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Welch, APRN, NP-C 22 The Village Blvd, Winter Haven, FL 33880-1612 Ph: (863) 287-5354 | Ashley Welch, APRN, NP-C 4935 Southfork Dr, Lakeland, FL 33813-2000 Ph: (863) 646-3376 |
News Archive
Overweight Latino children who consume lots of sugar-especially in sugary drinks-show signs of beta cell decline, a precursor of type 2 diabetes, according to researchers at the Keck School of Medicine of the University of Southern California.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
Study findings support the use of the Overall Anxiety Severity And Impairment Scale as a brief measure of anxiety in the outpatient clinical setting.
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
Amgen, the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million.
› Verified 1 days ago
Glenda Kaminski, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1360 | |
Patricia Lynn Creach, RNFA Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 636-871-3218 Fax: 863-284-1730 | |
Kara Elizabeth Bailey, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1100 | |
Lou Ann Marie Albano, ARNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 5985 S Florida Ave, Lakeland, FL 33813 Phone: 863-644-8459 Fax: 863-644-8450 |